Big Pharma

This is a placeholder. First-pass content lands here once the semiconductor cluster has been migrated and the template proven out.

What this cluster is

Plain-language overview goes here.

Value chain

Discovery → preclinical → clinical (Phase 1/2/3) → regulatory submission → manufacturing → commercialization → post-market surveillance.

Players & structure

Top-10 by revenue, plus context players (CROs, CDMOs, specialty distributors).

Trends

• 1yr — near-term shifts.
• 3yr — structural changes.
• 5yr — directional bets.

Regulations

FDA (CDER, CBER), GxP (GMP/GCP/GLP), 21 CFR Part 11, HIPAA touchpoints, EMA parallels for global players.

Glossary

NDA, BLA, IND, GxP, CMC, CRO, CDMO, biosimilar, orphan drug, breakthrough designation.

Sources & further reading

TBD.